Harbin Gloria Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 73.8% in First Half of 2022

Harbin Gloria Pharmaceuticals Co.,Ltd. (哈尔滨誉衡药业股份有限公司) (002437.SZ) reported a net profit of 31.8 million yuan in the first half of 2022, down 73.8% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 4% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 55.9%.